About ALKOMEX PHARMA
ALKOMEX PHARMA is a company based in Noida (India) founded in 2015. It operates as a B2B. The company has 9 employees. ALKOMEX PHARMA operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
- Headquarter Noida, India
- Employees 9
- SectorsHealthcare
- Website alkomexpharma.com
- Legal Name Alkomex Pharma Private Limited
- Date of Incorporation 10 Apr, 2017
- Jurisdiction Delhi, India
- Annual Revenue₹23.66 Cr
FY 2025 · -12% YoY
- Net Profit₹2.62 Cr
FY 2025 · 11% margin
- EBITDA₹4.02 Cr
FY 2025 · 17% margin
- Employee Count9
Associated legal entities of ALKOMEX PHARMA
ALKOMEX PHARMA operates through Alkomex Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Alkomex Pharma Private Limited CIN U24303DL2017PTC315829 | Active | 10 Apr 2017 | Delhi, Delhi | ₹23.7 Cr | 9 | 3 | View details |
Board of directors of Alkomex Pharma Private Limited (ALKOMEX PHARMA)
Alkomex Pharma Private Limited is the primary company behind ALKOMEX PHARMA. The board of Alkomex Pharma Private Limited currently have 3 directors; the longest-serving is Piyush Mittal, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Piyush Mittal DIN 00162353 | Director | 10 Apr 2017 | 9 yrs 6 mo | Alkomex Pharma Private Limited |
| Leena Mittal DIN 01264920 | Director | 10 Apr 2017 | 9 yrs 6 mo | Alkomex Pharma Private Limited |
| Raghav Piyush Mittal DIN 06652791 | Director | 18 Feb 2020 | 6 yrs 7 mo | Alkomex Pharma Private Limited |
Financials of ALKOMEX PHARMA
Figures of Alkomex Pharma Private Limited, the primary company behind ALKOMEX PHARMA, for FY 2025. Revenue was ₹23.66 Cr (-12% year on year). Net profit was ₹2.62 Cr (11% margin). EBITDA was ₹4.02 Cr (17% margin). Revenue has grown at a compounded annual rate of -10% over three years and +11% over five years.
- ₹23.66 CrRevenue · FY 2025 · -12% YoY
- ₹2.62 CrNet profit · 11% margin
- ₹4.02 CrEBITDA · 17% margin
- ₹1 LakhPaid-up capital
- 9Employees (provident fund records)
- -10%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Alkomex Pharma Private Limited are on its company page.
Detailed financial statements for ALKOMEX PHARMA
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of ALKOMEX PHARMA
ALKOMEX PHARMA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $11.53M | 161 | Provider of medical equipment, devices, and drugs distribution services | |
| mahaveermedi.com | 2016 | Bengaluru, India | – | 588 | Serves as a distributor of a wide range of pharmaceutical drugs. | |
| dipnapharmachem.com | 2011 | Ahmedabad, India | – | – | Distributor of pharmaceutical raw materials |
Detailed competitors of ALKOMEX PHARMA
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to ALKOMEX PHARMA
10 companies that operate in the same segment as ALKOMEX PHARMA (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ALKOMEX PHARMA
ALKOMEX PHARMA was founded in 2015.
ALKOMEX PHARMA is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
ALKOMEX PHARMA has 9 employees.
The primary company behind ALKOMEX PHARMA, Alkomex Pharma Private Limited, reported revenue of ₹23.66 Cr for FY 2025, down 12% year on year.
ALKOMEX PHARMA, based in Noida, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and product and service distribution. A pharmaceutical company delivering a range of products and services to the industry. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
ALKOMEX PHARMA's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.
ALKOMEX PHARMA operates through Alkomex Pharma Private Limited.
The legal entities of ALKOMEX PHARMA currently have 3 directors, including Piyush Mittal, Leena Mittal, Raghav Piyush Mittal.